Recruiting
Pharmacokinetic Study of Vorasidenib in Severe Hepatically Impaired and Matched-Control Participants
NCT07250633
- Conditions
- Normal Hepatic Function, Severe Hepatic Impairment
- Locations
-
- Arizona Clinical Trials Chandler, Arizona, United States
- Orlando Clinical Research Center Orlando, Florida, United States
- American Research Corporation San Antonio, Texas, United States